Media Center

Filter by year:

Sep 24, 2024

Generate:Biomedicines Announces Multi-Target Collaboration with Novartis to Discover and Develop Protein Therapeutics with Generative AI

Jun 13, 2024

Generate:Biomedicines Expands Board of Directors with the Appointment of Rupert Vessey, M.D., Ph.D., and Nancy Simonian, M.D.

Apr 30, 2024

Generate:Biomedicines Expands C-suite with Chief Corporate Affairs Officer and Chief Technical Operations Officer

Jan 04, 2024

Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 15, 2023

Generate:Biomedicines Announces Publication of its Chroma Model in Nature: A Transformative Generative AI for Protein Therapeutics

Nov 01, 2023

Generate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AI

Sep 14, 2023

Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics

Jun 26, 2023

Generate:Biomedicines Unveils State-of-the-Art CryoEM Laboratory to Accelerate Generative AI Drug Discovery and Development

Jun 12, 2023

Generate:Biomedicines Appoints Dr. Alexandra Snyder as Executive Vice President, Research & Development

'